White blood cells were found to enter the spleen primarily via the blood vessels in the red pulp and are then migrated to the other structures of the spleen, revealed the research groups at the University of Turku in Finland led by Academy Research Fellow Maija Hollmén and Academician of Science, Professor of Immunology Sirpa Jalkanen. Additionally, the researchers were able to confirm that the Clever-1 (Common Lymphatic and Vascular Endothelial Receptor-1) molecule found by the group earlier controls white blood cell trafficking to both mouse and human spleen.
Contrary to prior belief, the white blood cells enter the spleen primarily via vessels in the red pulp. The research results change thoroughly our perception of the spleen producing antibodies vital for the human body.
Spleen is our largest lymphoid organ. Its function is to eliminate outdated red blood cells and to produce antibodies against pathogens. Outdated red blood cells are eliminated in the spleen's red pulp and antibodies are produced in the white pulp.
So far, white blood cells have been believed to enter the spleen from the circulation through the marginal zone surrounding the white pulp. However, no molecule controlling white blood cell trafficking has been identified in any of the laboratories working in the trafficking field in spite of three decades of research.
"White blood cells entering the spleen directly attach to the Clever-1 molecule on the vessel wall. In addition, Clever-1 controls expression of other trafficking-associated molecules produced by the vessel. Such a molecule is for example the attractant for antibody-producing white blood cells," says Hollmén.
"The research results change our perception of the spleen all the way to the textbook level," adds Jalkanen.